Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of approximately 10.7% in Australia. It is becoming an increasingly common cause of cancer mortality. The therapeutic model for PDAC remains limited, especially for those with metastatic disease on presentation. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Talbot, Alice, Talbot, Thomas, Shaughnessy, Emma, Glass, Aisling, Das, Adarsh, Watanabe, Yuki, Cheng, Daniel, Johansson, Mikael, Rao, Samarth, Yusoff, Ian, Tang, Colin, White, Rohen, Dean, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643600/
https://www.ncbi.nlm.nih.gov/pubmed/37969823
http://dx.doi.org/10.21037/jgo-23-488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643600/
https://www.ncbi.nlm.nih.gov/pubmed/37969823
http://dx.doi.org/10.21037/jgo-23-488

Ejemplares similares